{"id":1191,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2018-07-25","marketCap":136.2052459716797,"name":"Aquestive Therapeutics Inc","phone":"19089411900.0","outstanding":66.7300033569336,"symbol":"AQST","website":"https://aquestive.com/","industry":"Pharmaceuticals"},"price":2.01375,"year":2023,"month":11,"day":23,"weekday":"Thursday","title":"Potential Impact of Global Supply Chain Disruptions on Aquestive Therapeutics Inc Stock and its Industry","date":"2023-11-23","url":"/posts/2023/11/23/AQST","content":[{"section":"Supply Chain Vulnerabilities","text":"Aquestive Therapeutics Inc operates in the pharmaceutical industry, which is highly dependent on global supply chains for sourcing raw materials, manufacturing drugs, and distributing products. The industry is vulnerable to disruptions in the supply chain due to various factors such as geopolitical tensions, natural disasters, and pandemics."},{"section":"Impact on Aquestive Therapeutics Inc Stock","text":"If there are disruptions in the global supply chain, Aquestive Therapeutics Inc may face challenges in procuring raw materials for drug manufacturing and delivering finished products to its customers. This can lead to production delays, decreased revenue, and increased costs. Such uncertainties can negatively impact the company's stock performance and investor confidence."},{"section":"Production and Manufacturing","text":"Supply chain disruptions can hamper Aquestive Therapeutics Inc's production and manufacturing capabilities. This can result in a shortage of drugs in the market, affecting the company's revenues and market share. Additionally, the company may incur additional costs to find alternative suppliers or implement contingency plans, further impacting profitability."},{"section":"Distribution and Market Access","text":"Global supply chain disruptions can also hinder Aquestive Therapeutics Inc's ability to distribute its products to various markets. Delays or disruptions in transportation systems can lead to reduced market access and potentially loss of market share to competitors. This can have a long-term impact on the company's growth prospects and stock performance."},{"section":"Reputation and Customer Trust","text":"Supply chain disruptions can harm Aquestive Therapeutics Inc's reputation and erode trust among its customers. Inconsistent product availability and quality issues due to disruptions can lead to customers seeking alternatives or switching to competitors. Rebuilding customer trust and loyalty can be a challenging task, impacting the company's long-term growth and stock value."},{"section":"Mitigation Strategies","text":"Aquestive Therapeutics Inc can implement mitigation strategies to minimize the potential impact of global supply chain disruptions. This may include diversifying their supplier base, establishing strategic stockpiles of critical raw materials, and developing robust contingency plans. Collaborating with suppliers and customers to strengthen the resilience of the supply chain can also help mitigate risks."},{"section":"Industry-wide Implications","text":"Global supply chain disruptions can have a cascading effect on the pharmaceutical industry as a whole. If multiple companies, including competitors, face challenges in their supply chains, it can lead to shortages of essential drugs, increased prices, and reduced healthcare access for patients. This can result in regulatory and policy interventions, affecting the overall industry landscape, including Aquestive Therapeutics Inc."},{"section":"Conclusion","text":"The potential impact of global supply chain disruptions on Aquestive Therapeutics Inc stock and its industry cannot be underestimated. The vulnerability of the pharmaceutical industry to supply chain disruptions highlights the importance for companies to proactively manage and mitigate risks. By implementing robust strategies, Aquestive Therapeutics Inc can minimize the potential negative effects and maintain continuity in their operations."}],"tags":["CrossOver55","Long","Pharmaceuticals"],"news":[{"category":"company","date":1700570375,"headline":"Those who invested in Aquestive Therapeutics (NASDAQ:AQST) a year ago are up 90%","id":124018875,"image":"https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b","symbol":"AQST","publisher":"Yahoo","summary":"The simplest way to invest in stocks is to buy exchange traded funds. But you can significantly boost your returns by...","url":"https://finance.yahoo.com/news/those-invested-aquestive-therapeutics-nasdaq-123935267.html"},{"category":"company","date":1700566260,"headline":"New Strong Buy Stocks for November 21st","id":124018095,"image":"https://media.zenfs.com/en/zacks.com/0fa1b9432d97e5ca64290e9723467d9d","symbol":"AQST","publisher":"Yahoo","summary":"AQST, RBT, HARP, VVI and AVTX have been added to the Zacks Rank #1 (Strong Buy) List on November 21, 2023.","url":"https://finance.yahoo.com/news/strong-buy-stocks-november-21st-113100920.html"},{"category":"company","date":1700154006,"headline":"Aquestive Therapeutics (AQST) Upgraded to Strong Buy: Here's What You Should Know","id":123940874,"image":"https://media.zenfs.com/en/zacks.com/a41b81fe729c761f3f94f42ff348f70c","symbol":"AQST","publisher":"Yahoo","summary":"Aquestive Therapeutics (AQST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.","url":"https://finance.yahoo.com/news/aquestive-therapeutics-aqst-upgraded-strong-170006039.html"},{"category":"company","date":1699627208,"headline":"Is Aquestive Therapeutics (AQST) Stock Outpacing Its Medical Peers This Year?","id":123791219,"image":"https://media.zenfs.com/en/zacks.com/f889276f4a638f3c7a79c0e3e6b768c1","symbol":"AQST","publisher":"Yahoo","summary":"Here is how Aquestive Therapeutics (AQST) and Amneal Pharmaceuticals (AMRX) have performed compared to their sector so far this year.","url":"https://finance.yahoo.com/news/aquestive-therapeutics-aqst-stock-outpacing-144008654.html"},{"category":"company","date":1699621200,"headline":"Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies for Anaphylm™ at American College of Allergy Asthma and Immunology (ACAAI) Annual Meeting","id":123791220,"image":"https://media.zenfs.com/en/globenewswire.com/38848d827b0260ef9344c723ce1f4c5a","symbol":"AQST","publisher":"Yahoo","summary":"WARREN, N.J., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company” or “Aquestive”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that two posters recapping the positive data from pharmacokinetic (PK) and pharmacodynamic (PD) pre-clinical and clinical studies of Anaphylm™ (epinephrine) Sublingual Film will be presented at the American Col","url":"https://finance.yahoo.com/news/aquestive-therapeutics-present-positive-data-130000267.html"},{"category":"company","date":1699599840,"headline":"Aquestive Therapeutics to present PK, PD data for Anaphylm","id":123794673,"image":"","symbol":"AQST","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3206290348"}]}